| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/BF00254300 |
| P698 | PubMed publication ID | 6818080 |
| P2093 | author name string | K A Matthews | |
| K G Taylor | |||
| A D Wright | |||
| W G John | |||
| P2860 | cites work | Preparation and properties of a cholesterol oxidase from Nocardia sp. and its application to the enzymatic assay of total cholesterol in serum | Q28245376 |
| Sex differences in the relationships between obesity, alcohol consumption and cigarette smoking and serum lipid and apolipoprotein concentrations in a normal population | Q38575964 | ||
| Rapid estimation (2 1/2 hours) of glycosylated haemoglobin for routine purposes | Q39442248 | ||
| Serum high-density lipoproteins in peripheral vascular disease | Q39520834 | ||
| High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study | Q40070458 | ||
| Ischemic heart disease, atherosclerosis, and longevity. | Q45946702 | ||
| Relation of high-density lipoprotein cholesterol concentration to type of diabetes and its control | Q50828427 | ||
| Morbidity and mortality in diabetics in the Framingham population. Sixteen year follow-up study. | Q53751216 | ||
| Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. | Q54047035 | ||
| The continually changing 'natural history' of diabetes mellitus | Q67257664 | ||
| Evaluation of a new enzymatic kit for serum triglycerides | Q67754695 | ||
| Atherosclerosis in diabetes mellitus. Correlations with serum lipid levels, adiposity, and serum insulin level | Q70505248 | ||
| High-density lipoprotein cholesterol and apolipoprotein A-I levels at diagnosis in patients with non-insulin dependent diabetes | Q71570570 | ||
| Factors contributing to deaths of diabetics under fifty years of age. On behalf of the Medical Services Study Group and British Diabetic Association | Q72494259 | ||
| P433 | issue | 6 | |
| P921 | main subject | lipid | Q11367 |
| P304 | page(s) | 507-510 | |
| P577 | publication date | 1982-12-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | A prospective study of the effect of 12 months treatment on serum lipids and apolipoproteins A-I and B in Type 2 (non-insulin-dependent) diabetes | |
| P478 | volume | 23 |
| Q33678321 | A risk-benefit assessment of metformin in type 2 diabetes mellitus |
| Q73523484 | Acipimox attenuates hypertriglyceridemia in dyslipidemic noninsulin dependent diabetes mellitus patients without perturbation of insulin sensitivity and glycemic control |
| Q39659871 | Adverse cardiovascular effects of sulphonylurea drugs. Clinical significance |
| Q51636945 | Effect of sulfonylurea therapy on plasma lipids and high-density lipoprotein composition in non-insulin-dependent diabetes mellitus. |
| Q51451135 | Effects of Glimepiride vs Glibenclamide on Ischaemic Heart Disease Risk Factors and Glycaemic Control in Patients with Type 2 Diabetes Mellitus. |
| Q34452266 | Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study |
| Q37679034 | Glycosylated Haemoglobin (HbA1c) - A Marker of Circulating Lipids in Type 2 Diabetic Patients |
| Q37934820 | Hyperlipidemia in diabetes mellitus. |
| Q36240026 | Management of Hyperlipidemia in Diabetes Mellitus |
| Q43945425 | Prospective comparative study in NIDDM patients of metformin and glibenclamide with special reference to lipid profiles |
| Q24235718 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q24240522 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q24244739 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q24247978 | Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus |
| Q46357174 | Serum lipid and apolipoprotein levels in non-hypertensive lean NIDDM patients |
| Q38618657 | Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use. |
| Q36682315 | Treatment of diabetes: the effect on serum lipids and lipoproteins |
| Q51573792 | [Value of biguanide in therapy of diabetes mellitus]. |
Search more.